Q BioMed Updates Shareholders
Technology partner, Mannin Research, receives new R&D funding for COVID project and Several Milestones Expected in 2021
News provided by
Share this article
Share this article
NEW YORK, April 27, 2021 /PRNewswire/ Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, updates shareholders.
In March 2021,it was announced that our technology partner, Mannin Research Inc. (Mannin), is receiving up to CAD$1.7 million in research and development funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to support the pre-clinical development of a therapeutic to treat Acute Respiratory Distress Syndrome in COVID-19. This funding adds to approximately $7 million granted in Europe, which together will fund 65-75 percent of every dollar incurred to advance the Acute Respiratory Distress Syndrome therapy for COVID patients as well as a portfolio of therapeutic assets for vascular diseases currently i
Monday, April 19, 2021 5:08 pm
Dr. Philip Jerald Dugan, 84, former director and founder of the Cleveland and Athens Regional Cancer Centers, the Ocoee Regional Cancer Foundation, and a longtime resident of Birchwood, passed away on Friday, April 16, 2021, at home with his family after a courageous one-year battle with MD Syndrome.
A native of Los Angeles, Calif., he graduated from Loyala High School in 1954, later graduating with a bachelor of science degree from Loyola University of Los Angeles in 1958 and St. Louis Medical School in St. Louis in 1963.
Pursuing his medical career, he returned to Los Angeles with an internship at the Queen of Angels Hospital in Los Angeles in 1964, followed by a residency in radiology at the hospital in 1967.
Tuesday, April 20, 2021 8:50 am
Dr. Philip Jerald Dugan, 84, former director and founder of the Cleveland and Athens Regional Cancer Centers, the Ocoee Regional Cancer Foundation, and a longtime resident of Birchwood, passed away on Friday, April 16, 2021, at home with his family after a courageous one-year battle with MD Syndrome.
A native of Los Angeles, Calif., he graduated from Loyala High School in 1954, later graduating with a bachelor of science degree from Loyola University of Los Angeles in 1958 and St. Louis Medical School in St. Louis in 1963.
Pursuing his medical career, he returned to Los Angeles with an internship at the Queen of Angels Hospital in Los Angeles in 1964, followed by a residency in radiology at the hospital in 1967.
Q BioMed Updates Shareholders at Year End
Company Expects Several Milestones as Momentum Builds for 2021
News provided by
Share this article
Dear Fellow Shareholders,
As 2020 draws to a close, we join the rest of the world in looking forward to a new year with new beginnings and hope for a quick return to whatever the new normal will be. Leaving behind the constant threat of lockdowns and the interruption the COVID-19 pandemic has had on our lives will be a welcome change.
With that in mind we acknowledge that 2020 was not the year we promised and feel even more committed to achieving our stated goals. We learned a great deal about Q BioMed s place in the fragile world in which we live and operate. With the 20/20 view of hindsight, we are excited about the coming year.
MARYAM HAMIDI
IRON MOUNTAIN Dr. Maryam Hamidi, a radiation oncologist, has become the fourth provider on the cancer care team at Dickinson County Healthcare.
Hamidi previously served at University Radiologists in Springfield, Ill., and Mercyhealth Javon Bea Hospital in Rockford, Ill. She is board certified in radiation oncology and a member of the American Society of Therapeutic Radiation Oncology, American Society of Clinical Oncology and the European Society of Therapeutic Radiation Oncology.
She earned her medical degree from the University of Wisconsin-Madison and did her residency at New York Presbyterian and the Medical University of South Carolina. She completed a research fellowship at the UW-School of Medicine and Public Health.